Connective Capital Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,063
Closed -$97.4K 40
2023
Q4
$97.4K Buy
+2,063
New +$97.4K 0.08% 76